During the past decade, Arizona Clinical Research Center conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 23 clinical trials were completed, i.e. on average, 67.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Clinical Research Center" #1 sponsor was "Bristol-Myers Squibb" with 9 trials, followed by "CTI BioPharma" with 7 trials sponsored, "Arcus Biosciences, Inc." with 4 trials sponsored, "Astellas Pharma Inc" with 3 trials sponsored and "Chiron Corporation" with 3 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Clinical Research Center" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "OSI Pharmaceuticals" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Clinical Research Center" are "Colorectal Cancer" (10 trials), "Lung Cancer" (7 trials), "Breast Cancer" (6 trials), "HIV Infections" (6 trials) and "Pancreatic Cancer" (6 trials). Many other conditions were trialed in "Arizona Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Arizona Clinical Research Center" are "Drug" (109 trials), "Other" (12 trials), "Biological" (6 trials), "Procedure" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Bevacizumab" (6 trials), "Carboplatin" (5 trials), "Docetaxel" (5 trials) and "oxaliplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Clinical Research Center" are 105 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Arizona Clinical Research Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 79 completed trials in Arizona Clinical Research Center, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Clinical Research Center, 26 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".